{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,28]],"date-time":"2025-10-28T03:08:30Z","timestamp":1761620910014},"reference-count":68,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2005,6,1]],"date-time":"2005-06-01T00:00:00Z","timestamp":1117584000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/doi.wiley.com\/10.1002\/tdm_license_1.1"},{"start":{"date-parts":[[2006,6,9]],"date-time":"2006-06-09T00:00:00Z","timestamp":1149811200000},"content-version":"vor","delay-in-days":373,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2005,6]]},"DOI":"10.1080\/13556210500123019","type":"journal-article","created":{"date-parts":[[2005,9,7]],"date-time":"2005-09-07T06:16:15Z","timestamp":1126073775000},"page":"131-137","source":"Crossref","is-referenced-by-count":13,"title":["Constitutive opioid receptor activation: a prerequisite mechanism involved in acute opioid withdrawal"],"prefix":"10.1111","volume":"10","author":[{"given":"E","family":"Freye","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"JV","family":"Levy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2006,6,9]]},"reference":[{"key":"10.1080\/13556210500123019-BIB1|cit1","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1080\/13556210412331308994","article-title":"Morphine-induced changes of gene expression in the brain","volume":"10","author":"Ammon-Treiber","year":"2005","journal-title":"Addict Biol"},{"key":"10.1080\/13556210500123019-BIB2|cit2","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1046\/j.1471-4159.1995.65041636.x","article-title":"Phosphorylation and agonist-specific intracellular trafficking of an epitope-tagged mu-opioid receptor expressed in HEK 293 cells","volume":"65","author":"Arden","year":"1995","journal-title":"J Neurochem"},{"key":"10.1080\/13556210500123019-BIB3|cit3","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/0304-3959(95)00009-H","article-title":"Insights into the development of opioid tolerance","volume":"61","author":"Basbaum","year":"1995","journal-title":"Pain"},{"key":"10.1080\/13556210500123019-BIB4|cit4","first-page":"484","article-title":"Effects of naloxone and D-Phe-Cys-Try-D-Tyr-D-Trp-Arg-Thr-Pen-Thr-NH2 (CTAP) and the protein kinase inhibitor H7 and H8 on acute morphine dependence and antinociceptive tolerance in mice","volume":"277","author":"Bilsky","year":"1996","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1080\/13556210500123019-BIB5|cit5","first-page":"33","volume-title":"Narcotic antagonists","volume":"vol 8","author":"Blumberg","year":"1974"},{"key":"10.1080\/13556210500123019-BIB6|cit6","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/S0750-7658(83)80011-2","article-title":"Withdrawal syndrome after stopping fentanyl sedation in neurological intensive care","volume":"2","author":"Boulard","year":"1983","journal-title":"Ann Fr Anesth Reanim"},{"key":"10.1080\/13556210500123019-BIB7|cit7","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/270620a0","article-title":"Naloxone alters pain perception and somatosensory evoked potentials in normal subjects","volume":"270","author":"Buchsbaum","year":"1977","journal-title":"Nature"},{"key":"10.1080\/13556210500123019-BIB8|cit8","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/BF00427792","article-title":"Pain enhances naloxone-induced hyperalgesia in humans as assessed by somatosensory-evoked potentials","volume":"79","author":"Buchsbaum","year":"1983","journal-title":"Psychopharmacology"},{"key":"10.1080\/13556210500123019-BIB9|cit9","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/BF00433411","article-title":"Opiate analgesia and its antagonism in dental event-related potentials: evidence for placebo antagonism","volume":"79","author":"Butler","year":"1983","journal-title":"Psychopharmacology"},{"key":"10.1080\/13556210500123019-BIB10|cit10","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1056\/NEJMra023160","article-title":"Drug addiction","volume":"349","author":"Cami","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1080\/13556210500123019-BIB11|cit11","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/S0166-2236(02)02289-0","article-title":"Elevated levels of GluR1 in the midbrain: trigger for sensitization to drugs of abuse","volume":"25","author":"Carlezon","year":"2002","journal-title":"Trends Neurosci"},{"key":"10.1080\/13556210500123019-BIB12|cit12","first-page":"791","volume-title":"Advances in pain research and therapy","volume":"vol 3","author":"Chapmann","year":"1979"},{"key":"10.1080\/13556210500123019-BIB13|cit13","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/374421a0","article-title":"Adenylyl cyclases and the interaction between calcium and cAMP signalling","volume":"374","author":"Cooper","year":"1995","journal-title":"Nature"},{"key":"10.1080\/13556210500123019-BIB14|cit14","first-page":"137","volume-title":"Towards a new pharmacotherapy of pain","author":"Cox","year":"1991"},{"key":"10.1080\/13556210500123019-BIB15|cit15","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/0014-2999(85)90068-8","article-title":"Autoradiographic localisation of opiate receptors in rat small intestine","volume":"107","author":"Dashwood","year":"1985","journal-title":"Eur J Pharmacol"},{"key":"10.1080\/13556210500123019-BIB16|cit16","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/S0376-8716(01)00171-5","article-title":"Retention rate and illicit opioid use during methadone maintenance interventions: a meta-analysis","volume":"65","author":"Farre","year":"2002","journal-title":"Drug Alcohol Depend"},{"key":"10.1080\/13556210500123019-BIB17|cit17","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1097\/00000542-197710000-00009","article-title":"Acute pulmonary edema following naloxone reversal of high dose morphine anesthesia","volume":"47","author":"Flacke","year":"1977","journal-title":"Anesthesiology"},{"key":"10.1080\/13556210500123019-BIB18|cit18","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1080\/1355621031000117446","article-title":"Naltrexone implants can completely prevent early (1-month) relapse after opiate detoxification: a pilot study of two cohorts totalling 101 patients with a note on naltrexone blood levels","volume":"8","author":"Foster","year":"2003","journal-title":"Addict Biol"},{"key":"10.1080\/13556210500123019-BIB19|cit19","first-page":"281","article-title":"Somatosensory-evoked potentials (SEPs) are effected differently by mu- and kappa-selective opioids in the dog","volume":"2","author":"Freye","year":"1987","journal-title":"Funct Neurol"},{"key":"10.1080\/13556210500123019-BIB20|cit20","first-page":"551","article-title":"Somatosensory-evoked potentials for the evaluation of analgesic properties of nalbuphine in man","volume":"65","author":"Freye","year":"1986","journal-title":"Anesth Analg"},{"key":"10.1080\/13556210500123019-BIB21|cit21","first-page":"89","article-title":"Naloxone induces excitation of the cardiovascular system and a rise in myocardial oxygen consumption in fentanyl and meperidine-anesthetized dogs","volume":"33","author":"Freye","year":"1982","journal-title":"Acta Anaesth Belg"},{"key":"10.1080\/13556210500123019-BIB22|cit22","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1053\/eujp.2000.0187","article-title":"Acute abstinence syndrome following abrupt cessation of long-term use of tramadol (Ultram?): a case study","volume":"4","author":"Freye","year":"2000","journal-title":"Eur J Pain"},{"key":"10.1080\/13556210500123019-BIB23|cit23","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.neucli.2004.02.002","article-title":"Use of gabapentin for attenuation of symptoms following rapid opiate detoxification (ROD) - correlation with neurophysiological parameters","volume":"34","author":"Freye","year":"2004","journal-title":"Neurophysiol Clin"},{"key":"10.1080\/13556210500123019-BIB24|cit24","first-page":"6","article-title":"Studies on the abstinence-like overshoot following reversal of the potent 19-isoamyl derivative of etorphine with naloxone. A comparison with the opioids fentanyl and alfentanil","volume":"47","author":"Freye","year":"1997","journal-title":"Arzneimittelforschung"},{"key":"10.1080\/13556210500123019-BIB25|cit25","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1097\/00000539-200006000-00018","article-title":"14-Methoxymetopon, a potent opioid, induces no respiratory depression, less sedation, and less bradycardia than sufentanil in the dog","volume":"90","author":"Freye","year":"2000","journal-title":"Anesth Analg"},{"key":"10.1080\/13556210500123019-BIB26|cit26","first-page":"247","volume-title":"Opiates and endogenous opioid peptides","author":"Gildenberg","year":"1976"},{"key":"10.1080\/13556210500123019-BIB27|cit27","first-page":"116","article-title":"Katamnestische Entwicklung Opiatabh\u00e4ngiger nach Naltrexon-induziertem Entzug, naltrexongest\u00fctzter R\u00fcckfallprophylaxe und ambulanter psychosozialer","volume":"1","author":"G\u00f6lz","year":"2000","journal-title":"Nachsorge Suchttherapie"},{"key":"10.1080\/13556210500123019-BIB28|cit28","first-page":"656","article-title":"Protein kinase C activation increases the rate and magnitude of agonist-induced d-opioid receptor down regulation in NG108-15 cells","volume":"42","author":"Gucker","year":"1992","journal-title":"Mol Pharmacol"},{"key":"10.1080\/13556210500123019-BIB29|cit29","doi-asserted-by":"crossref","first-page":"5036","DOI":"10.1021\/bi00316a032","article-title":"Isoquinolinesulfonamides, novel and potent inhibitors of cyclic nucleotide dependent protein kinase","volume":"23","author":"Hidaka","year":"1984","journal-title":"C Biochemistry"},{"key":"10.1080\/13556210500123019-BIB30|cit30","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1002\/cpt197213178","article-title":"Evaluation of nalbuphine for abuse potential","volume":"13","author":"Jasinski","year":"1972","journal-title":"Clin Pharmacol Ther"},{"key":"10.1080\/13556210500123019-BIB31|cit31","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/978-3-642-66612-4_4","volume-title":"Drug addiction","volume":"vol 1","author":"Jasinski","year":"1977"},{"key":"10.1080\/13556210500123019-BIB32|cit32","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1097\/00001756-199401120-00035","article-title":"Expressed mu opiate receptor couples to adenylate cyclase and phosphatidyl inositol turnover","volume":"5","author":"Johnson","year":"1994","journal-title":"Neuroreport"},{"key":"10.1080\/13556210500123019-BIB33|cit33","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1001\/jama.1992.03480200058024","article-title":"A controlled trial of buprenorphine treatment for opioid dependence","volume":"267","author":"Johnson","year":"1992","journal-title":"JAMA"},{"key":"10.1080\/13556210500123019-BIB34|cit34","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/S0006-291X(84)80362-9","article-title":"1-(5-Isoquinolinesulfonyl)-2-methylpiperazine (H-7) is a selective inhibitor of protein kinase C in rabbit platelets","volume":"125","author":"Kawamoto","year":"1984","journal-title":"Biochem Biophys Res Comm"},{"key":"10.1080\/13556210500123019-BIB35|cit35","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1097\/00000542-199608000-00012","article-title":"Analgesic efficacy of low-dose ketamine. Somatosensory-evoked responses in relation to subjective pain ratings","volume":"85","author":"Kochs","year":"1996","journal-title":"Anesthesiology"},{"key":"10.1080\/13556210500123019-BIB36|cit36","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1176\/ajp.94.4.759","article-title":"Clinical studies of drug addiction. III. A critical review of the withdrawal treatments with method of evaluating abstinence syndromes","volume":"94","author":"Kolb","year":"1938","journal-title":"Am J Psychiatry"},{"key":"10.1080\/13556210500123019-BIB37|cit37","first-page":"101","article-title":"Phase II clinical trials of buprenorphine: detoxification and induction onto naltrexone","volume":"121","author":"Kosten","year":"1992","journal-title":"NIDA Res Monogr"},{"key":"10.1080\/13556210500123019-BIB38|cit38","first-page":"1686","article-title":"Analysis of delta opioid receptor activities stably expressed in CHO cells lines: function of receptor density","volume":"271","author":"Law","year":"1994","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1080\/13556210500123019-BIB39|cit39","first-page":"5","article-title":"Buprenorphine - background to its development as a treatment for opioid dependence","volume":"121","author":"Lewis","year":"1992","journal-title":"NIDA Res Monogr"},{"key":"10.1080\/13556210500123019-BIB40|cit40","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/0014-2999(83)90331-X","article-title":"[3H]-sulfentanil, a superior ligand for the mu-opiate receptor: binding properties and regional distribution in rat brain and spinal cord","volume":"87","author":"Leysen","year":"1983","journal-title":"Eur J Pharmacol"},{"key":"10.1080\/13556210500123019-BIB41|cit41","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1146\/annurev.pa.30.040190.001011","article-title":"Molecular characterization of opioid receptors","volume":"30","author":"Loh","year":"1990","journal-title":"Annu Rev Pharmacol Toxicol"},{"key":"10.1080\/13556210500123019-BIB42|cit42","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1203\/00006450-200101000-00013","article-title":"Buprenorphine substitution ameliorates spontaneous withdrawal in fentanyl-dependent rat pups","volume":"49","author":"Lohmann","year":"2001","journal-title":"Pediatr Res"},{"key":"10.1080\/13556210500123019-BIB43|cit43","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/0304-3959(95)00073-2","article-title":"Mechanisms of hyperalgesia and morphine tolerance: a current view of their possible interactions","volume":"62","author":"Mao","year":"1995","journal-title":"Pain"},{"key":"10.1080\/13556210500123019-BIB44|cit44","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/0304-3959(95)00023-L","article-title":"The development of morphine tolerance and dependence is associated with translocation of protein kinase","volume":"61","author":"Mayer","year":"1995","journal-title":"C Pain"},{"key":"10.1080\/13556210500123019-BIB45|cit45","first-page":"439","volume-title":"Animal pain, short CE","author":"Moore","year":"1979"},{"key":"10.1080\/13556210500123019-BIB46|cit46","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/0014-2999(94)90817-6","article-title":"A protein kinase inhibitor H-7, inhibits the development of tolerance to opioid antinociception","volume":"271","author":"Narita","year":"1994","journal-title":"Eur J Pharmacol"},{"key":"10.1080\/13556210500123019-BIB47|cit47","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0006-8993(94)90224-0","article-title":"Influence of chronic morphine treatment on proteine kinase C activity: comparison with butorphanol and implication for opioid tolerance","volume":"650","author":"Narita","year":"1994","journal-title":"Brain Res"},{"key":"10.1080\/13556210500123019-BIB48|cit48","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/0304-3959(90)90035-C","article-title":"A psychophysiological study in humans using phasic colonic distension as a noxious visceral stimulus","volume":"43","author":"Ness","year":"1990","journal-title":"Pain"},{"key":"10.1080\/13556210500123019-BIB49|cit49","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1016\/0896-6273(93)90213-B","article-title":"Drug addiction: a model for the molecular basis of neuronal plasticity","volume":"11","author":"Nestler","year":"1993","journal-title":"Neuron"},{"key":"10.1080\/13556210500123019-BIB50|cit50","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1080\/105504901750532094","article-title":"Molecular neurobiology of addiction","volume":"10","author":"Nestler","year":"2001","journal-title":"Am J Addict"},{"key":"10.1080\/13556210500123019-BIB51|cit51","first-page":"1551","article-title":"Sufentanil, a very potent and extremely safe intravenous morphine-like compound in mice, rats and dogs","volume":"26","author":"Niemegeers","year":"1976","journal-title":"Arzneimittelforschung"},{"key":"10.1080\/13556210500123019-BIB52|cit52","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1016\/0024-3205(79)90014-6","article-title":"Opiates, opioid peptides and single neurones","volume":"24","author":"North","year":"1979","journal-title":"Life Sci"},{"key":"10.1080\/13556210500123019-BIB53|cit53","first-page":"1","article-title":"Development of tolerance to the analgesic activity of mu agonists after continuous infusion of morphine, meperidine or fentanyl in rats","volume":"262","author":"Paronis","year":"1992","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1080\/13556210500123019-BIB54|cit54","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1046\/j.1360-0443.2000.95710698.x","article-title":"A comparsion of four buprenorphine dosing regimens using open-dosing procedures: is twice-weekly dosing possible","volume":"95","author":"Petry","year":"2000","journal-title":"Addiction"},{"key":"10.1080\/13556210500123019-BIB55|cit55","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/0006-291X(86)91087-9","article-title":"The modulatory role of myosin light chain phosphorylation in human platelet activation","volume":"140","author":"Saitoh","year":"1986","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1080\/13556210500123019-BIB56|cit56","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S0006-8993(02)03394-2","article-title":"Prolonged reversal of morphine tolerance with no reversal of dependence by protein kinase C inhibitors","volume":"958","author":"Smith","year":"2002","journal-title":"Brain Res"},{"key":"10.1080\/13556210500123019-BIB57|cit57","doi-asserted-by":"crossref","first-page":"S573","DOI":"10.1097\/00000542-197909001-00373","article-title":"Comparison of naloxone and naltrexone in man","volume":"51","author":"Smith","year":"1979","journal-title":"Anesthesiology"},{"key":"10.1080\/13556210500123019-BIB58|cit58","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1097\/00000542-199012000-00012","article-title":"Differential cross-tolerance between intrathecal morphine and sufentanil in the rat","volume":"73","author":"Sosnowski","year":"1990","journal-title":"Anesthesiology"},{"key":"10.1080\/13556210500123019-BIB59|cit59","first-page":"216","article-title":"Time course characteristics of tolerance development to continuously infused antinociceptive agents in rat spinal cord","volume":"251","author":"Stevens","year":"1989","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1080\/13556210500123019-BIB60|cit60","first-page":"281","article-title":"Exaggerated nociceptive responses on morphine withdrawal: roles of protein kinase","volume":"110","author":"Sweitzer","year":"2004","journal-title":"C e and g Pain"},{"key":"10.1080\/13556210500123019-BIB61|cit61","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/S0361-9230(00)00273-2","article-title":"A protein kinase inhibitor, H-7, blocks naloxone-precipitated changes in dopamine and its metabolites in the brains of opioid-dependent rats","volume":"52","author":"Tokuyama","year":"2000","journal-title":"Brain Res Bull"},{"key":"10.1080\/13556210500123019-BIB62|cit62","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S0304-3959(01)00311-6","article-title":"Mechanisms of opioid-induced pain and antinociceptive tolerance: descending fascilitation and spinal dynorphin","volume":"92","author":"Vanderah","year":"2001","journal-title":"Pain"},{"key":"10.1080\/13556210500123019-BIB63|cit63","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1002\/cpt1976203315","article-title":"Naltrexone: disposition, metabolism and effects after acute and chronic dosing","volume":"20","author":"Verebey","year":"1976","journal-title":"Clin Pharmacol Ther"},{"key":"10.1080\/13556210500123019-BIB64|cit64","volume-title":"Evaluation of new compounds for morphine-like physical dependence in the rhesus monkey","author":"Villarreal","year":"1968"},{"key":"10.1080\/13556210500123019-BIB65|cit65","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/0024-3205(94)90022-1","article-title":"Constitutive \u03bc opioid receptor activation as a regulatory mechanism underlying narcotic tolerance and dependence","volume":"54","author":"Wang","year":"1994","journal-title":"Life Sci"},{"key":"10.1080\/13556210500123019-BIB66|cit66","first-page":"78","volume-title":"Neurophysiologische Untersuchungen mit dem kurzwirksamen, intraven\u00f6sen Analgetikum Alfentanil","author":"Wauquier","year":"1982"},{"key":"10.1080\/13556210500123019-BIB67|cit67","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/0024-3205(82)90079-0","article-title":"Lack of antagonism by naloxone of the analgesic and locomotor stimulant actions of ketamine","volume":"31","author":"Wiley","year":"1982","journal-title":"Life Sci"},{"key":"10.1080\/13556210500123019-BIB68|cit68","doi-asserted-by":"crossref","first-page":"3779","DOI":"10.1073\/pnas.91.9.3779","article-title":"Primary stucture and functional expression of a guinea pig kappa opioid (dynorphin) receptor","volume":"91","author":"Xie","year":"1994","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["Addiction Biology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1080%2F13556210500123019","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/onlinelibrary.wiley.com\/wol1\/doi\/10.1080\/13556210500123019\/fullpdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,6,11]],"date-time":"2020-06-11T08:20:26Z","timestamp":1591863626000},"score":1,"resource":{"primary":{"URL":"http:\/\/doi.wiley.com\/10.1080\/13556210500123019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,6]]},"references-count":68,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2005,6]]}},"URL":"https:\/\/doi.org\/10.1080\/13556210500123019","archive":["Portico"],"relation":{},"ISSN":["1355-6215"],"issn-type":[{"value":"1355-6215","type":"print"}],"subject":[],"published":{"date-parts":[[2005,6]]}}}